Then they moved it?? |
Can someone answer closettraders post on LSE regarding company spend on here,i can't get my head around his calculations. |
Good to have the CMD approaching to maintain momentum. Hopefully a weekend Press mention and the EMD cash details waiting to burst forth. Is the worm about to turn I wonder. |
Good update and lots of buys but share price not moving much.
only shyte goes up these days on AIM. |
I am not not bothered as am not selling have held this long and the rns read well so no worries or rush |
Big buy order being completed hopefully and that's why it's been held back, massive upside here, forgot risky Ai stocks and get in this |
Yep very true so why exactly is it? |
£20k,£9k,£8K,£7k,£6k and more,all buys,if sells we would be down 10% ,play fair MM's. |
The buying is relentless,MM's got to take it higher! |
There is going to be an almighty rise here. |
 This tech-cum-energy stock could double in value.
It delivered record performance in 2024 and a strong order book supports bumper profits this year.
Published on January 30, 2025
by Simon Thompson
*Record second half trading performance
*Momentum has continued into the new financial year
*Share price rallies 14 per cent
Technology-enabled energy services provider eEnergy (EAAS: 4.75p) has doubled revenue to £21.1mn in the second half of 2024 and expects to report an underlying cash profit of £2.4mn for the six months. Backed by a £7mn contracted order book, the positive momentum has continued into the new financial year, too.
Importantly, eEnergy ended the year strongly, signing a £1mn contract with Newcastle College to deliver a full LED lighting conversion across 10 buildings in Newcastle and Carlisle. In addition, the group was appointed to the NHS Commercial Solutions Sustainable Estates Framework Agreement. It means eEnergy is in a prime position to assist NHS Trusts in lowering their energy bills and reducing their environmental impact. Specifically, the group helps organisations achieve their net zero goals by designing, funding and implementing energy-efficient projects (solar, electric vehicle charging and energy-efficient lighting).
The return to growth has been well received by investors after trading in the first half of 2024 was hampered by a weak balance sheet and exacerbated by weak market conditions. Lower energy prices and higher costs of finance led to lengthened customer decision-making cycles, culminating in a delay in contract signings. As a result eEnergy only reported first half revenue of £6mn. However, the disposal of its energy management division significantly strengthened the group’s financial position and the group closed the year with cash of £2.3mn and a debt-free balance sheet.
Positive tailwinds driving demand.
The Labour government’s pledge to drive net-zero more actively as one of its levers for growth is a major positive for eEnergy given that the public sector will lead this activity. Given the constraints on public finances, government-backed clients are signing up for more flexible financing arrangements, which enables them to adopt eEnergy’s products and services with no upfront capital expenditure. It’s a win-win, for the public purse, the environment and the company, too.
For the year ahead, house broker Canaccord Genuity is forecasting revenue of £28mn, cash profit of £3mn, pre-tax profit of £2.6mn, earnings per share (EPS) of 0.4p and a doubling of net cash to £4.6mn (1.2p). Canaccord pencils in £6mn of contingent deferred consideration from the energy management disposal, split equally in the 2025 and 2026 financial years, hence why it expects net cash to rise sharply to £8.1mn (2.1p) in 2026. Given the cash build, the £18mn market capitalisation company’s operational business will be in the price for only 5.5 times current year operating profit forecasts of £2.5mn by the year-end, a multiple that drops to 2.5 times next year assuming eEnergy can ramp up operating profit to £3.9mn, as Canaccord predict.
So, although the shares are trading below the 7.15p suggested entry level in my 2024 Bargain Shares Portfolio, the improving growth trajectory and 60 per cent discount to analysts’ 12p a share sum-of the-parts valuations highlight the chronic undervaluation and material re-rating potential. BUY. |
100%+rise needed just to hit year high,we now are in a much better position than then,more profit,more orders and no debt, brilliant company now in one of the best sectors under this crackpot Labour government. |
Anyone selling down here is crazy after reading the trading update,as the song goes
"Things can only get better" |
Hopefully so, although I expect we will start to see some selling pressure once we hit 5p, as has happened in the past.The extra payment from the EMD should help to push the share price upwards? |
This should just keep rising now :-) |
If you rewatch the last presentation Harvey says they will know the size of the first tranche by the date of this update. I presume they know by now or as was said earlier they are in dispute about the exact amount. Maybe not bound to RNS until amount and date due finalised. |
I think the results from the buyers of the EMD will need to provide the information.Until they do there can be no RNS. |
Agreed but public bodies in particular like health and education obliged to comply with the legislation pushing towards net zero. The no capital required offer would therefore appear even more attractive to my mind.On a separate note the EMD disposal figures were the thing I was looking for most in the update and glaringly absent. I hope this to facilitate another RNS maybe on the morning of the CMD. |
PCOK. Which is why I posed it as a question.
My experience of being in organisations that are actively cutting costs, is that you focus first on the low hanging fruit - stopping things, redundancies etc. before you engage management time in new cost saving initiatives.
This is on my watch list, I will see how the business performs over next six months or so. I want to see continued traction in industries that I know are struggling.
GLA. |
I think you need to have a look at what this company do. The USP is a no capital required solution so perfect for cash strapped and legislation obliged organisations. |
Decent results. Watching for now. My hesitation is that both the NHS and Uni sector are incredibly cash poor at the moment. Lots of redundancies in Russell Group Unis due to reduction in number of overseas students. When was the NHS nor under financial pressure?
Is this a catalyst for investing in more efficient energy or a reason not to engage at this time? |
really decent update IMO....DYOR will be adding... |
24% down on last year's share price yet in fantastic condition now, market is F..KED! |
It looks to me like they had to do some handy work in order to get the sale through !! Otherwise figures and future looking good. |
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
